These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23049204)

  • 21. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer.
    Bogdanski AM; van Hooft JE; Boekestijn B; Bonsing BA; Wasser MNJM; Klatte DCF; van Leerdam ME
    Fam Cancer; 2024 Aug; 23(3):323-339. PubMed ID: 38619782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine test can detect early stage pancreatic cancer.
    Bagcchi S
    Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762
    [No Abstract]   [Full Text] [Related]  

  • 23. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
    Caputo D; Caracciolo G
    Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
    Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients.
    Shin SH; Kim SC; Song KB; Hwang DW; Lee JH; Park KM; Lee YJ
    Surgery; 2018 Sep; 164(3):432-442. PubMed ID: 29884479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.
    Takayama R; Nakagawa H; Sawaki A; Mizuno N; Kawai H; Tajika M; Yatabe Y; Matsuo K; Uehara R; Ono K; Nakamura Y; Yamao K
    J Gastroenterol; 2010; 45(1):52-9. PubMed ID: 19789838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
    Babic A; Wolpin BM
    Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
    [No Abstract]   [Full Text] [Related]  

  • 28. Familial Pancreatic Cancer.
    Benzel J; Fendrich V
    Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
    Song J; Sokoll LJ; Pasay JJ; Rubin AL; Li H; Bach DM; Chan DW; Zhang Z
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):174-182. PubMed ID: 30333219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-Generation Sequencing in Pancreatic Cancer.
    Shen GQ; Aleassa EM; Walsh RM; Morris-Stiff G
    Pancreas; 2019 Jul; 48(6):739-748. PubMed ID: 31206465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
    Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
    Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.
    Laeseke PF; Chen R; Jeffrey RB; Brentnall TA; Willmann JK
    Radiology; 2015 Dec; 277(3):644-61. PubMed ID: 26599925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Pancreatic Cancer: Recommendation Statement.
    Am Fam Physician; 2019 Dec; 100(12):Online. PubMed ID: 31845783
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis and staging of pancreatic ductal adenocarcinoma.
    Guillén-Ponce C; Blázquez J; González I; de-Madaria E; Montáns J; Carrato A
    Clin Transl Oncol; 2017 Oct; 19(10):1205-1216. PubMed ID: 28612200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening.
    Hur C; Tramontano AC; Dowling EC; Brooks GA; Jeon A; Brugge WR; Gazelle GS; Kong CY; Pandharipande PV
    Pancreas; 2016 Aug; 45(7):1062-6. PubMed ID: 26692444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.
    Fong ZV; Winter JM
    Cancer J; 2012; 18(6):530-8. PubMed ID: 23187839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
    Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma.
    Park HD; Kang ES; Kim JW; Lee KT; Lee KH; Park YS; Park JO; Lee J; Heo JS; Choi SH; Choi DW; Kim S; Lee JK; Lee SY
    Proteomics; 2012 Dec; 12(23-24):3590-7. PubMed ID: 23065739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic cancer and cancer screening programs: from nihilism to hope.
    Pezzilli R; Corinaldesi R; Morselli-Labate AM
    JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.